Bluebee Teams Up With Aspera for Fast Transfer of Genomics Data for Clinical Applications

Bluebee Teams Up With Aspera for Fast Transfer of Genomics Data for Clinical Applications

ID: 462073

(Thomson Reuters ONE) -


Provider of High Performance Genome Analytics Platform Deploys Aspera On IBM
Cloud to Exchange Data With Hospitals, Diagnostic Test Providers, Research
Centers and Other Clients

ARMONK, N.Y., April 05, 2016 (GLOBE NEWSWIRE) -- IBM (NYSE:IBM) today announced
that Bluebee, a leading provider of high-performance genomics solutions, has
deployed high-speed file transfer solutions from Aspera, an IBM company, running
on the IBM Cloud and integrated directly into the Bluebee genome analytics
platform. Aspera transfers reduce the end-to-end turnaround time of
computational data analysis, enabling Bluebee to deliver results to clients
significantly faster and more efficiently than was previously possible.

Bluebee's genome analytics platform enables efficient pipeline processing by
combining best-in-class tools with a high-performance computational engine. The
addition of Aspera's flexible and highly scalable Aspera On Demand (AOD)
software supports Bluebee's users with high-speed, reliable and resilient
transfers even for the largest data sets, including entire genomes that can
reach up to 90 GB per sample.

Bluebee's clients submit samples of all sizes, the largest coming from cancer
centers, which typically submit 2-3 tumor cell samples along with a control
sample for each patient, bringing the total volume of NGS data to upwards of
360 GB per patient that must be uploaded to the platform.

Initial tests comparing FTPS and Aspera found that transfer speeds for a 10GB
file sent over the same network have increased by a factor of 6 with Aspera.

Tumor and other samples are collected, are prepped and sequenced in a Wet Lab,
and the resulting data is then transferred to Bluebee's Silicon Lab for
secondary analysis. Whole genomes, cancer sequencing data, agricultural data and
other large files are transferred while sequencing is ongoing to save time,




while smaller samples are uploaded in batches once sequencing is complete.

The fusion of technologies pairing Bluebee's advanced genome analytics
application and Aspera FASP® high-speed transfer technology supports fast,
efficient and affordable diagnosis, providing significant implications for
clinical settings. By enabling hospitals, diagnostic test providers, research
centers and other clients to quickly and securely transfer large volumes of
genomics data, Aspera shortens the data analysis turnaround time so data can be
interpreted and patients can be diagnosed and begin therapy as soon as possible.

AOD's pay-as-you-go model offering fits with Bluebee's usage-based billing to
eliminate the burden of time and capital expenditure that is incurred to manage
and maintain in-house infrastructure.

"When on-site infrastructure is not able to scale up with increasing mass data
volumes, sequence waiting lists are inevitably formed. This seriously hampers
the speed of diagnosis and delays research. Bluebee addresses this genome
analysis challenge by providing a highly scalable private cloud platform for
accelerated processing of mass volumes of NGS data, and the speed and resiliency
of the Aspera solution allows our clients to transfer huge data sets directly to
the platform," said Kurt Florus, CTO at Bluebee. "Together the solutions
significantly accelerate the turnaround time for data processing while at the
same time solving the data throughput issue. We strongly believe in the value
Aspera brings to our customers and in the competitive advantage the
collaboration gives us."

"In the field of genomic analysis, platforms like Bluebee can make computing,
processing and analysis as fast as imaginable, but the reality is the impact is
lost if the data takes forever to transfer. Shortening the time it takes to
transfer huge data volumes between labs, analysis platforms and the hospitals
that rely on this data for diagnosis will have a tremendous impact on clinics'
ability to treat patients in a timely manner," said Richard Heitmann, vice
president of marketing at Aspera.

Aspera CEO & co-founder Michelle Munson will co-present alongside Bluebee CEO
Hans Cobben: "How Bluebee & Others Solve the File Exchange Problem for
Bioinformatics," on Wednesday, April 6 at 2:55pm at Bio-IT World. Visit Aspera
at Booth #261.

About Aspera
Aspera, an IBM company, is the creator of next-generation transport technologies
that move the world's data at maximum speed regardless of file size, transfer
distance and network conditions. Part of IBM Cloud, Aspera software is powered
by the Emmy® award-winning FASP® protocol to deliver the fastest, most
predictable file-transfer, share and sync experience across on-premises, cloud,
and hybrid infrastructure. Aspera's core technology delivers unprecedented
control over bandwidth, complete security and uncompromising reliability.
Organizations across a variety of industries on six continents rely on Aspera
software for the business-critical transport of their digital assets. Please
visit http://www.asperasoft.com and follow us on Twitter(at)asperasoft for more
information.

About Bluebee
Bluebee provides high performance genomics solutions, enabling genomic labs to
substantially reduce cost and time-to-diagnosis. Bluebee's unique cloud-based
accelerated genomics platform enables fast, efficient and affordable processing
of large volumes of genomics data. With Bluebee's private-cloud based solutions,
labs can run their pipelines orders of magnitude faster without compromising the
algorithms and methods used, nor the flexibility required to provide quality,
sensitivity and reliability. Please visit www.bluebee.com and follow us on
Twitter (at)bluebeegenomics for more information.

Media contacts:
Americas/Asia: Kim Willsher, +1 (310) 569 2603
Europe: Louise Wells, +44 (0) 20 7403 8878
Red Lorry Yellow Lorry - Aspera's PR agency
aspera(at)rlyl.com




This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Aspera, Inc. via GlobeNewswire
[HUG#2000838]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Summary of FLSmidth & Co. A/S' Annual General Meeting Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.'s holding in Metso
Bereitgestellt von Benutzer: hugin
Datum: 05.04.2016 - 17:31 Uhr
Sprache: Deutsch
News-ID 462073
Anzahl Zeichen: 6952

contact information:
Town:

Emeryville



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 244 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Bluebee Teams Up With Aspera for Fast Transfer of Genomics Data for Clinical Applications"
steht unter der journalistisch-redaktionellen Verantwortung von

Aspera, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Aspera, Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z